2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.4% year on year to ...

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its ...

Pfizer and Novo Nordisk seem to want Metsera bad. Analysts are wondering, though: is the obesity biotech really worth this much effort?

A global conference showcasing AI-led scientific research revealed both the growing role of AI in academia and its persistent ...

Ironically enough, his initial downfall had nothing to do with Daraprim. Soon after he became infamous, federal prosecutors ...

In the world of biomedical innovation, few stories embody the spirit of perseverance, intuition, and collaboration quite like ...

Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced better-than-expected revenue in Q3 CY2025, with sales up 3.9% year on year to $701.3 million. The company’s full-year revenue ...

Once this policy is enacted, it will be illegal for Americans to retain any mental impression longer than that little haptic ...

Discover why Alexandria Real Estate Equities is a top REIT pick for long-term gains and dividends after a price dip. Click ...

The group says its vaccine business will recover in the medium term when falling immunisation rates cause a severe public ...